Hidekazu Ochiai

Changes in heart rate in patients with type 2 diabetes mellitus after treatment with luseogliflozin: Subanalysis of placebo‐controlled, double‐blind clinical trials

Motoaki Sano, Shi Chen, Hisae Imazeki et al. · Journal of Diabetes Investigation · 2018 · 56 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Sodium‐glucose cotransporter‐2 inhibitor luseogliflozin added to glucagon‐like peptide 1 receptor agonist liraglutide improves glycemic control with bodyweight and fat mass reductions in Japanese patients with type 2 diabetes: A 52‐week, open‐label, single‐arm study

Yutaka Seino, Daisuke Yabe, Takashi Sasaki et al. · Journal of Diabetes Investigation · 2017 · 51 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Efficacy and safety of luseogliflozin added to insulin therapy in Japanese patients with type 2 diabetes: a multicenter, 52-week, clinical study with a 16-week, double-blind period and a 36-week, open-label period

Yutaka Seino, Takashi Sasaki, Atsushi Fukatsu et al. · Current Medical Research and Opinion · 2018 · 24 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Luseogliflozin, an SGLT2 Inhibitor, in Japanese Patients With Mild/Moderate Hepatic Impairment: A Pharmacokinetic Study

Yoshishige Samukawa, Michio Sata, Kenichi Furihata et al. · Clinical Pharmacology in Drug Development · 2017 · 21 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

[Torsade de Pointes with T wave alternans in a patient receiving moderate dose of chlorpromazine: report of a case].

Hidekazu Ochiai, Mutsumi Kashiwagi, Toshiro Usui et al. · PubMed · 1990 · 16 citations

Medicine, Pharmacology, Pharmacotherapy +16